Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 12.79% is 152% above its 5-year average of -24.49%, near the high end of its 5-year range (-91.76%–12.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 87.10% above its 12-month average of 6.84%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 12.79%.
RETURN ON INVESTED CAPITAL (ROIC)
12.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
6.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-8.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-24.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+87.10%
CURRENT VS 3Y AVG
+258.53%
CURRENT VS 5Y AVG
+152.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+135.88%
vs the sector median at left
Xeris Biopharma Holdings, Inc.
Market Cap
$1.73B
Return on Invested Capital (ROIC)
12.79%
TTM Avg
6.84%
3Y Avg
-8.07%
5Y Avg
-24.49%
Market Cap
$1.74B
Return on Invested Capital (ROIC)
9.23%
TTM Avg
-10.32%
3Y Avg
-22.84%
5Y Avg
-22.10%
Market Cap
$1.75B
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-54.60%
3Y Avg
-46.39%
5Y Avg
-38.46%
Market Cap
$1.71B
Return on Invested Capital (ROIC)
10.03%
TTM Avg
-6.49%
3Y Avg
-7.14%
5Y Avg
-3.83%
Market Cap
$1.71B
Return on Invested Capital (ROIC)
-42.87%
TTM Avg
-29.07%
3Y Avg
-38.98%
5Y Avg
-32.39%
Market Cap
$1.76B
Return on Invested Capital (ROIC)
4.23%
TTM Avg
3.43%
3Y Avg
4.08%
5Y Avg
4.12%
Market Cap
$1.77B
Return on Invested Capital (ROIC)
-26.88%
TTM Avg
-21.15%
3Y Avg
-18.76%
5Y Avg
-12.71%
Market Cap
$1.69B
Return on Invested Capital (ROIC)
-74.69%
TTM Avg
-59.02%
3Y Avg
-89.37%
5Y Avg
-89.37%
Market Cap
$1.78B
Return on Invested Capital (ROIC)
-52.66%
TTM Avg
-61.09%
3Y Avg
-54.75%
5Y Avg
-42.45%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | $1.73B | 12.79% | 6.84% | -8.07% | -24.49% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 9.23% | -10.32% | -22.84% | -22.10% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.75B | -54.45% | -54.60% | -46.39% | -38.46% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 10.03% | -6.49% | -7.14% | -3.83% |
| Personalis, Inc. (PSNL)vs › | $1.71B | -42.87% | -29.07% | -38.98% | -32.39% |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | 4.23% | 3.43% | 4.08% | 4.12% |
| Novocure Ltd (NVCR)vs › | $1.77B | -26.88% | -21.15% | -18.76% | -12.71% |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.69B | -74.69% | -59.02% | -89.37% | -89.37% |
| Absci Corporation (ABSI)vs › | $1.78B | -52.66% | -61.09% | -54.75% | -42.45% |
| Xencor, Inc. (XNCR)vs › | $1.79B | -33.60% | -20.55% | -16.70% | -12.38% |
ROIC
12.8%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 12.79% |
| 2026-03-31 | 12.84% |
| 2025-12-31 | 8.89% |
| 2025-09-30 | 3.77% |
| 2025-06-30 | -4.10% |
| 2025-03-31 | -9.68% |
| 2024-12-31 | -14.15% |
| 2024-09-30 | -18.42% |
| 2024-06-30 | -14.51% |
| 2024-03-31 | -17.07% |
| 2023-12-31 | -19.35% |
| 2023-09-30 | -20.49% |
| 2023-06-30 | -25.37% |
| 2023-03-31 | -27.57% |
| 2022-12-31 | -30.25% |
| 2022-09-30 | -49.07% |
| 2022-06-30 | -47.47% |
| 2022-03-31 | -46.96% |
| 2021-12-31 | -51.11% |
| 2021-09-30 | -91.76% |
| 2021-06-30 | -65.17% |
| 2021-03-31 | -51.37% |
| 2020-12-31 | -63.80% |
| 2020-09-30 | -67.67% |
| 2020-06-30 | -79.25% |
| 2020-03-31 | -132.37% |
| 2019-12-31 | -149.89% |
| 2019-09-30 | -99.62% |
| 2019-06-30 | -81.76% |
| 2019-03-31 | -49.50% |
| 2018-12-31 | -54.02% |
| 2018-09-30 | -37.28% |
| 2018-06-30 | -31.66% |
| 2018-03-31 | -64.37% |
| 2017-12-31 | -66.34% |
